申请人:Kaleido Biosciences, Inc.
公开号:US11169101B2
公开(公告)日:2021-11-09
Aspects of the disclosure relate to oligosaccharide compositions and methods of making the same. Also provided are methods of using oligosaccharide compositions as microbiome metabolic therapies for reducing ammonia levels and for the treatment of related diseases.
本公开的各个方面涉及寡糖组合物及其制造方法。还提供了将寡糖组合物用作微生物组代谢疗法以降低氨水平和治疗相关疾病的方法。